Similar companies
Income Statement (NONE)
| Q2 '25 | QoQ | |
|---|---|---|
| Operating expense | 41M | 27.2% |
| Net Income | -43M | 83.1% |
| EBITDA | -41M | 79.8% |
Balance Sheet (NONE)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 265M | 3.7% |
| Total Liabilities | 80M | 51.7% |
| Total Equity | 185M | 16.8% |
| Shares Outstanding | 85M | 2% |
Cash Flow (NONE)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | -30M | 0.6% |
| Cash from investing | -40M | 75.7% |
| Cash from financing | 20M | 1861.1% |
EPS
Financial Highlights for Mind Medicine (MindMed) in Q2 '25
Operating Expenses for this period were 41M, showing a 27.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -43M, showing a -83.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -41M, showing a -79.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Mind Medicine (MindMed) faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
